title: Long-term consumption of saponins derived from Platycodi radix (22 years old) enhances hepatic insulin sensitivity and glucose-stimulated insulin secretion in 90 % pancreatectomized diabetic rats fed a high-fat diet.
abstract: Crude saponins derived from Chinese Platycodi radix have been reported to prevent increases in body weight and liver TAG in mice fed a high-fat diet. We investigated the effects of an extract (PR) taken from Korean Platycodi radix, which is cultivated for 22 years in the ground (Jangsaeng doraji), and its saponins (PRS) on insulin resistance and glucose-stimulated insulin secretion in 90 % pancreatectomized diabetic rats fed high-fat diets. Four groups were orally supplemented with 2 g PR, 0.2 g PRS, 20 mg rosiglitazone (positive control) or 0.5 g cellulose (negative control) per kg body weight on a daily basis for 8 weeks. We found that PRS lowered body weight, visceral fat mass and serum leptin levels in pancreatectomized rats in comparison to the control. PR enhanced first- and second-phase insulin secretion while PRS stimulated only first-phase insulin secretion. Glucose infusion rates to maintain euglycaemia at hyperinsulinaemic states decreased in a descending order of rosiglitazone, PRS, PR and control, but they increased hepatic glucose output in the same order. This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, Akt). Improved hepatic insulin signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic glucose output accordingly. In conclusion, PRS principally improves glucose homeostasis by enhancing hepatic insulin sensitivity as a consequence of reducing fat storage and stimulating insulin signalling in diabetic rats. In addition, PR contains components that promote glucose-stimulated insulin secretion.
authors.affiliation: Food Functional Research Division, Korean Food Research Institutes, Sungnam 463-746, Korea.
authors.forename: Dae Yeon
authors.initials: DY
authors.lastname: Kwon
authors.forename: Young Seob
authors.initials: YS
authors.lastname: Kim
authors.forename: Sang Mee
authors.initials: SM
authors.lastname: Hong
authors.forename: Sunmin
authors.initials: S
authors.lastname: Park
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004041:Dietary Fats / Q000008:administration & dosage*; D005947:Glucose / Q000494:pharmacology; D006706:Homeostasis; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000378:metabolism; D007723:Korea; D008099:Liver / Q000378:metabolism*; D008297:Male; D010180:Pancreatectomy; D010936:Plant Extracts / Q000008:administration & dosage*; D031238:Platycodon / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077154:Rosiglitazone; D012503:Saponins / Q000008:administration & dosage*; D045162:Thiazolidinediones / Q000494:pharmacology; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D004041:Dietary Fats; D007004:Hypoglycemic Agents; D007328:Insulin; D010936:Plant Extracts; D012503:Saponins; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D005947:Glucose